Skip to content

Clinical trials

Completed Phase 2 Tourette Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tourette Syndrome Phase: Phase 2 Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20081
20101
20112
20121
20131
20141
20151
20162
20172
20183
20192
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurocrine Biosciences5
Emalex Biosciences Inc.3
Yale University3
National Center for Research Resources (NCRR)2
Abide Therapeutics1
Asarina Pharma1
AstraZeneca1
Boehringer Ingelheim1
China Medical University Hospital1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tourette Syndrome24
Tic Disorders6
Tics3
Mental Disorders2
Neurologic Manifestations2
Obsessive-Compulsive Disorder2
Rare Diseases2
Excoriation Disorder1
Hoarding Disorder1
Trichotillomania1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.